Trial · NCT07003191
Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes
NCT07003191, Active not recruiting, Sun Yat-sen University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes. Trials, record NCT07003191. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07003191
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes
- NCT number
- NCT07003191
- Status
- Active not recruiting
- Enrollment
- 2,600 participants, estimated
- Lead sponsor
- Sun Yat-sen University
- Conditions
- Type 2 Diabetes
- Interventions
- Metformin Hydrochloride and Empagliflozin tables (Fixed-Dose Combination)
- First posted
- 2025-06-04
- Last updated
- 2025-06-04
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 6-month clinical glycemic control rate | 6 months | 6-month clinical glycemic control rate (clinical control defined as HbA1c \< 7.0%) |
| Secondary | Change in HbA1c from baseline | 12 months | Change in HbA1c from baseline at 12 months |
| Secondary | Change of β cell function | 12 months | Change of β cell function at 12 months |
| Secondary | Change of insulin sensitivity | 12 months | Change of insulin sensitivity indicators at the end of study |
| Secondary | Change of lipid profiles | 12 months | Change of cholesterol, Triglyceride, high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) at the end of study |
| Secondary | Change of body weight | 12 months | Change of body weight at the end of study |
| Secondary | Changes in echocardiographic indicators in type 2 diabetes patients with cardiovascular disease | 12 months | Changes in echocardiographic indicators in type 2 diabetes patients with cardiovascular disease at the end of study |
| Secondary | Change of blood pressure | 12 months | Change of blood pressure at the end of study |
| Secondary | Change of Quality of life assessment (EQ-5D) | 12 months | Change of Quality of life assessment (EQ-5D) at the end of study |
| Secondary | Incidence of adverse events | 12 months | incidence of adverse events at the end of study |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07003191
GET https://conductscience.org/api/trials/v1/NCT07003191/registered